The deficiency of CXCL13 can effectively alleviate the occurrence and the development of DSS-induced colitis by limiting CD4+CXCR5+ T cells migration from mesenteric lymph nodes to secondary lymphoid organs, and thereby inducing local regulatory B cells increase in colon. Here, CXCR5 is linked to colitis.